SEARCH

SEARCH BY CITATION

References

  • Ambye, L., Rasmussen, S., Fenger, M., Jorgensen, T., Borch-Johnsen, K., Madsbad, S., & Urhammer, S. A. (2005) Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome. Diabetes Res Clin Pract 67, 175179.
  • Andersen, G., Wegner, L., Yanagisawa, K., Rose, C. S., Lin, J., Glumer, C., Drivsholm, T., Borch-Johnsen, K., Jorgensen, T., Hansen, T., Spiegelman, B. M., & Pedersen, O. (2005) Evidence of an association between genetic variation of the coactivator PGC-1beta and obesity. J Med Genet 42, 402407.
  • Andrulionyte, L., Peltola, P., Chiasson, J. L., & Laakso, M. (2006) Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: The STOP-NIDDM trial. Diabetes 55, 21482152.
  • Barroso, I., Luan, J., Sandhu, M. S., Franks, P. W., Crowley, V., Schafer, A. J., O'Rahilly, S., & Wareham, N. J. (2006) Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes. Diabetologia 49, 501505.
  • Cai, H., Zheng, W., Xiang, Y. B., Xu, W. H., Yang, G., Li, H., & Shu, X. O. (2007) Dietary patterns and their correlates among middle-aged and elderly Chinese men: A report from the Shanghai Men's Health Study. Br J Nutr 98, 10061013.
  • Carey, V. J., Walters, E. E., Colditz, G. A., Solomon, C. G., Willett, W. C., Rosner, B. A., Speizer, F. E., & Manson, J. E. (1997) Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses’ Health Study. Am J Epidemiol 145, 614619.
  • Chan, J. M., Rimm, E. B., Colditz, G. A., Stampfer, M. J., & Willett, W. C. (1994) Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17, 961969.
  • Colditz, G. A., Willett, W. C., Stampfer, M. J., Manson, J. E., Hennekens, C. H., Arky, R. A., & Speizer, F. E. (1990) Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 132, 501513.
  • Esterbauer, H., Oberkofler, H., Krempler, F., & Patsch, W. (1999) Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression. Genomics 62, 98102.
  • Evans, D., Aberle, J., Wendt, D., Wolf, A., Beisiegel, U., & Mann, W. A. (2001) A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPARalpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus. J Mol Med 79, 198204.
  • Flavell, D. M., Ireland, H., Stephens, J. W., Hawe, E., Acharya, J., Mather, H., Hurel, S. J., & Humphries, S. E. (2005) Peroxisome proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetes. Diabetes 54, 582586.
  • Gregg, E. W., Cadwell, B. L., Cheng, Y. J., Cowie, C. C., Williams, D. E., Geiss, L., Engelgau, M. M., & Vinicor, F. (2004) Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. Diabetes Care 27, 28062812.
  • Guo, W.L., Tang, Y., Han, X. Y., & Ji, L. N. (2011) Meta-analysis of the association of Pro12Ala polymorphism of peroxisome proliferator activated receptor gamma gene with type 2 diabetes in Chinese Han population. Zhongguo Yi Xue Ke Xue Yuan Xue.Bao 33, 593599.
  • Helmrich, S. P., Ragland, D. R., Leung, R. W., & Paffenbarger, R. S.,Jr. (1991) Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325, 147152.
  • Hu, C., Jia, W., Fang, Q., Zhang, R., Wang, C., Lu, J., & Xiang, K. (2006) Peroxisome proliferator-activated receptor (PPAR) delta genetic polymorphism and its association with insulin resistance index and fasting plasma glucose concentrations in Chinese subjects. Diabet Med 23, 13071312.
  • Hu, F. B., Leitzmann, M. F., Stampfer, M. J., Colditz, G. A., Willett, W. C., & Rimm, E. B. (2001a) Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med 161, 15421548.
  • Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G., & Willett, W. C. (2001b) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345, 790797.
  • King, H., Aubert, R. E., & Herman, W. H. (1998) Global burden of diabetes, 1995–2025: Prevalence, numerical estimates, and projections. Diabetes Care 21, 14141431.
  • King, H. & Rewers, M. (1993) Diabetes in adults is now a Third World problem. World Health Organization Ad Hoc Diabetes Reporting Group. Ethn Dis 3, (Suppl) 6774.
  • Kunej, T., Globocnik, P. M., Dovc, P., Peterlin, B., & Petrovic, D. (2004) A Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with type 2 diabetes in Caucasians. Folia Biol.(Praha) 50, 157158.
  • Lin, J., Handschin, C., & Spiegelman, B. M. (2005) Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1, 361370.
  • Lu, L., Wu, Y., Qi, Q., Liu, C., Gan, W., Zhu, J., Li, H., & Lin, X. (2012) Associations of type 2 diabetes with common variants in PPARD and the modifying effect of vitamin D among middle-aged and elderly Chinese. PLoS One 7, e34895.
  • Manson, J. E., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Willett, W. C., Krolewski, A. S., Rosner, B., Hennekens, C. H., & Speizer, F. E. (1991) Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 338, 774778.
  • Matthews, C. E., Shu, X. O., Jin, F., Dai, Q., Hebert, J. R., Ruan, Z. X., Gao, Y. T., & Zheng, W. (2001) Lifetime physical activity and breast cancer risk in the Shanghai Breast Cancer Study. Br J Cancer 84, 9941001.
  • Matthews, C. E., Shu, X.O., Yang, G., Jin, F., Ainsworth, B. E., Liu, D., Gao, Y. T., & Zheng, W. (2003) Reproducibility and validity of the Shanghai Women's Health Study physical activity questionnaire. Am J Epidemiol 158, 11141122.
  • Medina-Gomez, G., Gray, S., & Vidal-Puig, A. (2007) Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1). Public Health Nutr 10, 11321137.
  • Nelson, T. L., Fingerlin, T. E., Moss, L., Barmada, M. M., Ferrell, R. E., & Norris, J. M. (2007) The peroxisome proliferator-activated receptor gamma coactivator-1 alpha gene (PGC-1alpha) is not associated with type 2 diabetes mellitus or body mass index among Hispanic and non Hispanic Whites from Colorado. Exp Clin Endocrinol Diabetes 115, 268275.
  • Ohlson, L. O., Larsson, B., Svardsudd, K., Welin, L., Eriksson, H., Wilhelmsen, L., Bjorntorp, P., & Tibblin, G. (1985) The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 34, 10551058.
  • Park, K. S., Shin, H. D., Park, B. L., Cheong, H. S., Cho, Y. M., Lee, H. K., Lee, J. Y., Lee, J. K., Kim, H. T., Park, C. S., Han, B. G., Kimm, K., & Oh, B. (2006) Putative association of peroxisome proliferator-activated receptor gamma co-activator 1beta (PPARGC1B) polymorphism with Type 2 diabetes mellitus. Diabet Med 23, 635642.
  • Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., Landaker, E. J., Goldfine, A. B., Mun, E., DeFronzo, R., Finlayson, J., Kahn, C. R., & Mandarino, L. J. (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 100, 84668471.
  • Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829839.
  • Robitaille, J., Brouillette, C., Houde, A., Lemieux, S., Perusse, L., Tchernof, A., Gaudet, D., & Vohl, M. C. (2004) Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome. J Hum Genet 49, 482489.
  • Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., Prokunina-Olsson, L., Ding, C. J., Swift, A. J., Narisu, N., Hu, T., Pruim, R., Xiao, R., Li, X. Y., Conneely, K. N., Riebow, N. L., Sprau, A. G., Tong, M., White, P. P., Hetrick, K. N., Barnhart, M. W., Bark, C. W., Goldstein, J. L., Watkins, L., Xiang, F., Saramies, J., Buchanan, T. A., Watanabe, R. M., Valle, T. T., Kinnunen, L., Abecasis, G. R., Pugh, E. W., Doheny, K. F., Bergman, R. N., Tuomilehto, J., Collins, F. S., & Boehnke, M. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 13411345.
  • Shin, H. D., Park, B. L., Kim, L. H., Jung, H. S., Cho, Y. M., Moon, M. K., Park, Y. J., Lee, H. K., & Park, K. S. (2004) Genetic polymorphisms in peroxisome proliferator-activated receptor delta associated with obesity. Diabetes 53, 847851.
  • Shu, X. O., Long, J., Cai, Q., Qi, L., Xiang, Y. B., Cho, Y. S., Tai, E. S., Li, X., Lin, X., Chow, W. H., Go, M. J., Seielstad, M., Bao, W., Li, H., Cornelis, M. C., Yu, K., Wen, W., Shi, J., Han, B. G., Sim, X. L., Liu, L., Qi, Q., Kim, H. L., Ng, D. P., Lee, J. Y., Kim, Y. J., Li, C., Gao, Y. T., Zheng, W., & Hu, F. B. (2010) Identification of new genetic risk variants for type 2 diabetes. PLoS Genet 6, e1001127. doi: 10.1371/journal.pgen.1001127.
  • Sigal, R. J., Kenny, G. P., Wasserman, D. H., & Castaneda-Sceppa, C. (2004) Physical activity/exercise and type 2 diabetes. Diabetes Care 27, 25182539.
  • Spiegelman, B. M. (2007) Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators. Novartis Found Symp 287, 6063.
  • Stumvoll, M., Fritsche, A., t’Hart, L. M., Machann, J., Thamer, C., Tschritter, O., Van Haeften, T. W., Jacob, S., Dekker, J. M., Maassen, J. A., Machicao, F., Schick, F., Heine, R. J., & Haring, H. (2004) The Gly482Ser variant in the peroxisome proliferator-activated receptor gamma coactivator-1 is not associated with diabetes-related traits in non-diabetic German and Dutch populations. Exp Clin Endocrinol Diabetes 112, 253257.
  • Sun, L., Yang, Z., Jin, F., Zhu, X. Q., Qu, Y. C., Shi, X. H., & Wang, L. (2006) The Gly482Ser variant of the PPARGC1 gene is associated with Type 2 diabetes mellitus in northern Chinese, especially men. Diabet Med 23, 10851092.
  • Tai, E. S., Corella, D., Demissie, S., Cupples, L. A., Coltell, O., Schaefer, E. J., Tucker, K. L., & Ordovas, J. M. (2005) Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study. J Nutr 135, 397403.
  • Tai, E. S., Demissie, S., Cupples, L. A., Corella, D., Wilson, P. W., Schaefer, E. J., & Ordovas, J. M. (2002) Association between the PPARA L162V polymorphism and plasma lipid levels: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 22, 805810.
  • Tonjes, A. & Stumvoll, M. (2007) The role of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma in diabetes risk. Curr Opin Clin Nutr Metab Care 10, 410414.
  • Uthurralt, J., Gordish-Dressman, H., Bradbury, M., Tesi-Rocha, C., Devaney, J., Harmon, B., Reeves, E. K., Brandoli, C., Hansen, B. C., Seip, R. L., Thompson, P. D., Price, T. B., Angelopoulos, T. J., Clarkson, P. M., Moyna, N. M., Pescatello, L. S., Visich, P. S., Zoeller, R. F., Gordon, P. M., & Hoffman, E. P. (2007) PPARalpha L162V underlies variation in serum triglycerides and subcutaneous fat volume in young males. BMC Med Genet 8, 55. doi:10.1186/1471-2350-8-55.
  • Villegas, R., Williams, S., Gao, Y., Cai, Q., Li, H., Elasy, T., Cai, H., Edwards, T., Xiang, Y. B., Zheng, W., Long, J., & Ou, S. X. (2011) Peroxisome proliferator-activated receptor delta (PPARD) genetic variation and type 2 diabetes in middle-aged Chinese women. Ann Hum Genet 75, 621629.
  • Vimaleswaran, K. S., Radha, V., Anjana, M., Deepa, R., Ghosh, S., Majumder, P. P., Rao, M. R., & Mohan, V. (2006) Effect of polymorphisms in the PPARGC1A gene on body fat in Asian Indians. Int J Obes (Lond), 30, 884891.
  • Vimaleswaran, K. S., Radha, V., Ghosh, S., Majumder, P. P., Deepa, R., Babu, H. N., Rao, M. R., & Mohan, V. (2005) Peroxisome proliferator-activated receptor-gamma co-activator-1alpha (PGC-1alpha) gene polymorphisms and their relationship to Type 2 diabetes in Asian Indians. Diabet Med 22, 15161521.
  • Wang, F., Han, X. Y., Ren, Q., Zhang, X. Y., Han, L. C., Luo, Y. Y., Zhou, X. H., & Ji, L. N. (2009) Effect of genetic variants in KCNJ11, ABCC8, PPARG and HNF4A loci on the susceptibility of type 2 diabetes in Chinese Han population. Chin Med J (Engl) 122, 24772482.
  • Wang, Y. B., Yu, Y. C., Li, Z., Wang, C., Wang, J. Y., & Wu, G. T. (2005) Study on the relationship between polymorphisms of peroxisome proliferators-activated receptor-gamma coactivator-1alpha gene and type 2 diabetes in Shanghai Hans in China. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22, 453456.
  • Wei, M., Gibbons, L. W., Mitchell, T. L., Kampert, J. B., Lee, C. D., & Blair, S. N. (1999) The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men. Ann Intern Med 130, 8996.
  • Zhang, S. L., Lu, W. S., Yan, L., Wu, M. C., Xu, M. T., Chen, L. H., & Cheng, H. (2007) Association between peroxisome proliferator-activated receptor-gamma coactivator-1alpha gene polymorphisms and type 2 diabetes in southern Chinese population: Role of altered interaction with myocyte enhancer factor 2C. Chin Med J (Engl) 120, 18781885.
  • Zheng, W., Chow, W. H., Yang, G., Jin, F., Rothman, N., Blair, A., Li, H. L., Wen, W., Ji, B. T., Li, Q., Shu, X. O., & Gao, Y. T. (2005) The Shanghai Women's Health Study: Rationale, study design, and baseline characteristics. Am J Epidemiol 162, 11231131.
  • Zheng, W., Long, J., Gao, Y. T., Li, C., Zheng, Y., Xiang, Y. B., Wen, W., Levy, S., Deming, S. L., Haines, J. L., Gu, K., Fair, A. M., Cai, Q., Lu, W., & Shu, X. O. (2009) Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 41, 324328.
  • Zhu, S., Liu, Y., Wang, X., Wu, X., Zhu, X., Li, J., Ma, J., Gu, H. F., & Liu, Y. (2009) Evaluation of the association between the PPARGC1A genetic polymorphisms and type 2 diabetes in Han Chinese population. Diabetes Res Clin Pract 86, 168172.